Neuropace Inc reports results for the quarter ended in March - Earnings Summary

NeuroPace

03/06/2021 12:53

* Neuropace Inc  NPCE.OQ  reported a quarterly adjusted loss of
$32.73​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 28
cents per share.
* Revenue was $11.22 million​;  analysts expected $11.00
million. 
* Neuropace Inc's reported EPS for the quarter was a loss of
$32.73​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* The company reported a quarterly loss of $8.81 million.
* Wall Street's median 12-month price target for Neuropace Inc
is $25.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated June 3 at 11:53 a.m. GMT.
​All figures in US dollars